Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2013 Filed Mar 12, 2013 21:17 UTC |
RAPP EDWARD JDirector
|
PurchaseCommon stock, $0.01 par value | 100 | $37.66 | $3,766.00 |
DisclosureSEC source: 0001179110-13-004967 · edgar.xml · nonDerivative · entry 4 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Read SEC document |
| March 11, 2013 Filed Mar 12, 2013 21:17 UTC |
RAPP EDWARD JDirector
|
PurchaseCommon stock, $0.01 par value | 100 | $37.66 | $3,766.11 |
DisclosureSEC source: 0001179110-13-004967 · edgar.xml · nonDerivative · entry 3 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Read SEC document |
| March 11, 2013 Filed Mar 12, 2013 21:17 UTC |
RAPP EDWARD JDirector
|
PurchaseCommon stock, $0.01 par value | 200 | $37.66 | $7,532.88 |
DisclosureSEC source: 0001179110-13-004967 · edgar.xml · nonDerivative · entry 2 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Read SEC document |
| March 11, 2013 Filed Mar 12, 2013 21:17 UTC |
RAPP EDWARD JDirector
|
PurchaseCommon stock, $0.01 par value | 1,200 | $37.67 | $45,204.00 |
DisclosureSEC source: 0001179110-13-004967 · edgar.xml · nonDerivative · entry 1 RAPP EDWARD J · CIK 0001171780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Read SEC document |
| March 08, 2013 Filed Mar 12, 2013 21:08 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
SaleCommon stock, $0.01 par value | 23,644 | $37.50 | $886,650.00 |
DisclosureSEC source: 0001179110-13-004964 · edgar.xml · nonDerivative · entry 2 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,320 Read SEC document |
| March 08, 2013 Filed Mar 12, 2013 21:08 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
SaleCommon stock, $0.01 par value | 4,305 | $37.58 | $161,781.90 |
DisclosureSEC source: 0001179110-13-004964 · edgar.xml · nonDerivative · entry 1 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,964 Read SEC document |
| March 08, 2013 Filed Mar 12, 2013 21:09 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
SaleCommon stock, $0.01 par value | 496 | $37.50 | $18,600.00 |
DisclosureSEC source: 0001179110-13-004965 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,272 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:06 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Tax withholdingCommon stock, $0.01 par value | 1,479 | $36.73 | $54,323.67 |
DisclosureSEC source: 0001179110-13-004009 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,768 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:07 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
Tax withholdingCommon stock, $0.01 par value | 9,407 | $36.73 | $345,519.11 |
DisclosureSEC source: 0001179110-13-004010 · edgar.xml · nonDerivative · entry 1 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,269 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:07 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
Tax withholdingCommon stock, $0.01 par value | 19,517 | $36.73 | $716,859.41 |
DisclosureSEC source: 0001179110-13-004011 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,784 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:08 UTC |
HURWICH THOMAS A.VP, Controller
|
Tax withholdingCommon stock, $0.01 par value | 2,191 | $36.73 | $80,475.43 |
DisclosureSEC source: 0001179110-13-004013 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,418 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:09 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Tax withholdingCommon stock, $0.01 par value | 5,260 | $36.73 | $193,199.80 |
DisclosureSEC source: 0001179110-13-004014 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,656 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:09 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
Tax withholdingCommon stock, $0.01 par value | 12,960 | $36.73 | $476,020.80 |
DisclosureSEC source: 0001179110-13-004015 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,835 Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 17:10 UTC |
GONZALEZ RICHARD ADirector · Chairman of the Board and CEO
|
Tax withholdingCommon stock, $0.01 par value | 7,716 | $36.73 | $283,408.68 |
DisclosureSEC source: 0001179110-13-004017 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,306 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:03 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
Tax withholdingCommon stock, $0.01 par value | 464 | $37.58 | $17,437.12 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 4 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,165 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:04 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
Tax withholdingCommon stock, $0.01 par value | 7,982 | $37.58 | $299,963.56 |
DisclosureSEC source: 0001179110-13-003025 · edgar.xml · nonDerivative · entry 2 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,676 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:05 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
Tax withholdingCommon stock, $0.01 par value | 421 | $37.58 | $15,821.18 |
DisclosureSEC source: 0001179110-13-003026 · edgar.xml · nonDerivative · entry 2 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,247 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:06 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
Tax withholdingCommon stock, $0.01 par value | 15,024 | $37.58 | $564,601.92 |
DisclosureSEC source: 0001179110-13-003029 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,301 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:05 UTC |
HURWICH THOMAS A.VP, Controller
|
Tax withholdingCommon stock, $0.01 par value | 2,265 | $37.58 | $85,118.70 |
DisclosureSEC source: 0001179110-13-003028 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,609 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:06 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Tax withholdingCommon stock, $0.01 par value | 2,912 | $37.58 | $109,432.96 |
DisclosureSEC source: 0001179110-13-003030 · edgar.xml · nonDerivative · entry 2 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,916 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:06 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
Tax withholdingCommon stock, $0.01 par value | 9,826 | $37.58 | $369,261.08 |
DisclosureSEC source: 0001179110-13-003031 · edgar.xml · nonDerivative · entry 2 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,795 Read SEC document |
| February 19, 2013 Filed Feb 19, 2013 19:07 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
Tax withholdingCommon stock, $0.01 par value | 3,130 | $37.58 | $117,625.40 |
DisclosureSEC source: 0001179110-13-003033 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,022 Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 22:04 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
Exercise / conversionOption (right to buy) · Derivative | 29,650 | $0.00 Strike: $27.29 | $0.00 |
DisclosureSEC source: 0001179110-13-003277 · edgar.xml · derivative · entry 4 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,650 Underlying: Common stock · 29,650 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 22:04 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
Tax withholdingCommon stock, $0.01 par value | 25,345 | $37.58 | $952,465.10 |
DisclosureSEC source: 0001179110-13-003277 · edgar.xml · nonDerivative · entry 2 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,981 Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 22:04 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
Exercise / conversionCommon stock, $0.01 par value | 29,650 | $27.29 | $809,267.10 |
DisclosureSEC source: 0001179110-13-003277 · edgar.xml · nonDerivative · entry 1 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2013 Filed Feb 20, 2013 00:03 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
Tax withholdingCommon stock, $0.01 par value | 496 | $37.58 | $18,639.68 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 3 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,629 Read SEC document |
| February 17, 2013 Filed Feb 20, 2013 00:03 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
Tax withholdingCommon stock, $0.01 par value | 534 | $37.58 | $20,067.72 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 2 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,125 Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:03 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
GrantOption (right to buy) · Derivative | 87,040 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · derivative · entry 5 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,040 Underlying: Common stock · 87,040 shares Expires 2023-02-13 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 29,014 on 02/14/2014, 29,013 on 02/14/2015, and 29,013 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:03 UTC |
RICHMOND TIMOTHY J.SVP, Human Resources
|
GrantCommon stock, $0.01 par value | 42,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003024 · edgar.xml · nonDerivative · entry 1 RICHMOND TIMOTHY J. · CIK 0001563523 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,659 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:04 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
GrantOption (right to buy) · Derivative | 62,020 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003025 · edgar.xml · derivative · entry 4 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,020 Underlying: Common stock · 62,020 shares Expires 2023-02-13 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 20,674 on 02/14/2014, 20,673 on 02/14/2015, and 20,673 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:04 UTC |
LEONARD JOHN MSVP, Chief Scientific Officer
|
GrantCommon stock, $0.01 par value | 30,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003025 · edgar.xml · nonDerivative · entry 1 LEONARD JOHN M. · CIK 0001563584 · SVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,658 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:05 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
GrantOption (right to buy) · Derivative | 74,520 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003026 · edgar.xml · derivative · entry 5 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,520 Underlying: Common stock · 74,520 shares Expires 2023-02-13 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 24,840 on 02/14/2014, 24,840 on 02/14/2015, and 24,840 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:05 UTC |
SALEKI-GERHARDT AZITASVP, Operations
|
GrantCommon stock, $0.01 par value | 36,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003026 · edgar.xml · nonDerivative · entry 1 SALEKI-GERHARDT AZITA · CIK 0001563545 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,668 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:06 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
GrantOption (right to buy) · Derivative | 145,510 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003029 · edgar.xml · derivative · entry 3 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,510 Underlying: Common stock · 145,510 shares Expires 2023-02-13 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 48,504 on 02/14/2014, 48,503 on 02/14/2015, and 48,503 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:06 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
GrantCommon stock, $0.01 par value | 71,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003029 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,325 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:05 UTC |
HURWICH THOMAS A.VP, Controller
|
GrantOption (right to buy) · Derivative | 35,620 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003028 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,620 Underlying: Common stock · 35,620 shares Expires 2023-02-13 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 11,874 on 02/14/2014, 11,873 on 02/14/2015, and 11,873 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:05 UTC |
HURWICH THOMAS A.VP, Controller
|
GrantCommon stock, $0.01 par value | 17,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003028 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,874 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:06 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
GrantOption (right to buy) · Derivative | 115,830 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003030 · edgar.xml · derivative · entry 4 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,830 Underlying: Common stock · 115,830 shares Expires 2023-02-13 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 38,610 on 02/14/2014, 38,610 on 02/14/2015, and 38,610 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:06 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
GrantCommon stock, $0.01 par value | 56,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003030 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,828 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:06 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
GrantOption (right to buy) · Derivative | 115,830 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003031 · edgar.xml · derivative · entry 4 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,830 Underlying: Common stock · 115,830 shares Expires 2023-02-13 F3 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 38,610 on 02/14/2014, 38,610 on 02/14/2015, and 38,610 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:06 UTC |
ALBAN CARLOSEVP, Commercial Operations
|
GrantCommon stock, $0.01 par value | 56,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003031 · edgar.xml · nonDerivative · entry 1 ALBAN CARLOS · CIK 0001474632 · EVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,621 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2013 Filed Feb 19, 2013 19:07 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
GrantOption (right to buy) · Derivative | 526,430 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003033 · edgar.xml · derivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,430 Underlying: Common stock · 526,430 shares Expires 2023-02-13 F2 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 175,477 on 02/14/2014, 175,476 on 02/14/2015, and 175,477 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 19, 2013 19:07 UTC |
GONZALEZ RICHARD AChairman of the Board and CEO
|
GrantCommon stock, $0.01 par value | 257,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003033 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,152 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Exercise / conversionOption (right to buy) · Derivative | 2,177 | $0.00 Strike: $32.43 | $0.00 |
DisclosureSEC source: 0001179110-13-002287 · edgar.xml · derivative · entry 6 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,177 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Exercise / conversionOption (right to buy) · Derivative | 2,390 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001179110-13-002287 · edgar.xml · derivative · entry 5 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 2,390 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Tax withholdingCommon stock, $0.01 par value | 4,188 | $37.14 | $155,542.32 |
DisclosureSEC source: 0001179110-13-002287 · edgar.xml · nonDerivative · entry 3 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,128 Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Exercise / conversionCommon stock, $0.01 par value | 2,177 | $32.43 | $70,592.49 |
DisclosureSEC source: 0001179110-13-002287 · edgar.xml · nonDerivative · entry 2 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
CHASE WILLIAM JEVP, Chief Financial Officer
|
Exercise / conversionCommon stock, $0.01 par value | 2,390 | $32.00 | $76,481.20 |
DisclosureSEC source: 0001179110-13-002287 · edgar.xml · nonDerivative · entry 1 CHASE WILLIAM J · CIK 0001563572 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
Exercise / conversionOption (right to buy) · Derivative | 165 | $0.00 Strike: $32.57 | $0.00 |
DisclosureSEC source: 0001179110-13-002288 · edgar.xml · derivative · entry 5 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 165 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2013 Filed Feb 8, 2013 22:04 UTC |
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GC
|
Exercise / conversionOption (right to buy) · Derivative | 3,611 | $0.00 Strike: $32.47 | $0.00 |
DisclosureSEC source: 0001179110-13-002288 · edgar.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · EVP, Bus.Dev.,Ext.Aff.&GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 3,611 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.